MML Investors Services LLC Acquires 8,831 Shares of Relx Plc (NYSE:RELX)

MML Investors Services LLC increased its holdings in Relx Plc (NYSE:RELX - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 121,643 shares of the technology company's stock after buying an additional 8,831 shares during the period. MML Investors Services LLC's holdings in Relx were worth $5,525,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Virtu Financial LLC bought a new position in Relx in the 3rd quarter worth about $223,000. Wilmington Savings Fund Society FSB bought a new position in shares of Relx in the third quarter valued at approximately $125,000. Peapack Gladstone Financial Corp increased its holdings in Relx by 5.7% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock worth $234,000 after acquiring an additional 267 shares during the period. Franklin Resources Inc. lifted its stake in Relx by 3.3% in the 3rd quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock worth $873,000 after purchasing an additional 588 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Relx by 14.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company's stock valued at $39,225,000 after purchasing an additional 104,999 shares in the last quarter. Institutional investors own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on RELX shares. The Goldman Sachs Group started coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating for the company. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Redburn Atlantic began coverage on shares of Relx in a report on Wednesday, January 8th. They set a "buy" rating for the company. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy".

Relx Trading Up 0.4 %

Shares of RELX traded up $0.23 during trading hours on Wednesday, hitting $54.02. The company had a trading volume of 240,471 shares, compared to its average volume of 706,489. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. Relx Plc has a 52-week low of $40.77 and a 52-week high of $54.22. The stock's 50 day moving average price is $49.66 and its 200 day moving average price is $48.33. The firm has a market cap of $99.98 billion, a P/E ratio of 29.08, a P/E/G ratio of 2.73 and a beta of 0.84.

Relx Increases Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a dividend of $0.5586 per share. This is a positive change from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. Relx's dividend payout ratio is currently 59.68%.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.